| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peritoneal Neoplasms | 9 | 2025 | 55 | 5.690 |
Why?
|
| Malaria, Vivax | 19 | 2024 | 27 | 5.330 |
Why?
|
| Plasmodium vivax | 19 | 2024 | 27 | 4.270 |
Why?
|
| Malaria, Falciparum | 18 | 2024 | 72 | 4.230 |
Why?
|
| Colorectal Neoplasms | 12 | 2025 | 652 | 3.990 |
Why?
|
| Appendiceal Neoplasms | 6 | 2025 | 20 | 3.780 |
Why?
|
| Cytoreduction Surgical Procedures | 9 | 2025 | 48 | 3.370 |
Why?
|
| Plasmodium falciparum | 19 | 2024 | 97 | 2.910 |
Why?
|
| Hyperthermia, Induced | 5 | 2023 | 58 | 2.760 |
Why?
|
| Malaria | 12 | 2024 | 105 | 2.510 |
Why?
|
| Adenocarcinoma | 9 | 2025 | 1070 | 2.490 |
Why?
|
| Antibodies, Protozoan | 15 | 2023 | 95 | 2.320 |
Why?
|
| Trans-Activators | 7 | 2025 | 838 | 2.290 |
Why?
|
| Circulating Tumor DNA | 2 | 2025 | 39 | 1.690 |
Why?
|
| Homeodomain Proteins | 6 | 2025 | 589 | 1.640 |
Why?
|
| Microbiota | 3 | 2023 | 443 | 1.610 |
Why?
|
| Enhancer Elements, Genetic | 6 | 2025 | 323 | 1.570 |
Why?
|
| Retina | 6 | 2025 | 501 | 1.520 |
Why?
|
| Gastrointestinal Microbiome | 5 | 2024 | 823 | 1.520 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2021 | 168 | 1.400 |
Why?
|
| Protozoan Proteins | 10 | 2023 | 135 | 1.340 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 10 | 2020 | 377 | 1.290 |
Why?
|
| Pancreatic Neoplasms | 5 | 2021 | 739 | 1.270 |
Why?
|
| Rectal Neoplasms | 4 | 2025 | 81 | 1.230 |
Why?
|
| Transcription Factors | 10 | 2025 | 2734 | 1.230 |
Why?
|
| Humans | 139 | 2025 | 134145 | 1.230 |
Why?
|
| Malaria Vaccines | 7 | 2021 | 24 | 1.220 |
Why?
|
| Photoreceptor Cells | 2 | 2021 | 94 | 1.210 |
Why?
|
| Biological Products | 4 | 2022 | 138 | 1.200 |
Why?
|
| Biomarkers, Tumor | 9 | 2025 | 1721 | 1.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 512 | 1.170 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2024 | 171 | 1.160 |
Why?
|
| Plasmodium | 3 | 2022 | 11 | 1.090 |
Why?
|
| Lung Neoplasms | 11 | 2022 | 1783 | 1.040 |
Why?
|
| Antigens, Protozoan | 10 | 2020 | 80 | 1.030 |
Why?
|
| Combined Modality Therapy | 8 | 2025 | 1312 | 1.020 |
Why?
|
| Laparoscopy | 5 | 2025 | 520 | 1.020 |
Why?
|
| Melanoma | 5 | 2022 | 969 | 1.000 |
Why?
|
| Survival Rate | 12 | 2025 | 2212 | 0.880 |
Why?
|
| Proto-Oncogene Proteins B-raf | 5 | 2025 | 222 | 0.870 |
Why?
|
| Binding Sites | 8 | 2025 | 1386 | 0.870 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2025 | 179 | 0.840 |
Why?
|
| Pseudomyxoma Peritonei | 1 | 2023 | 2 | 0.830 |
Why?
|
| Hepatectomy | 1 | 2024 | 124 | 0.820 |
Why?
|
| B7-H1 Antigen | 2 | 2020 | 129 | 0.790 |
Why?
|
| Signal Transduction | 15 | 2023 | 4936 | 0.780 |
Why?
|
| Antineoplastic Agents | 6 | 2023 | 1853 | 0.750 |
Why?
|
| Animals | 44 | 2025 | 36520 | 0.750 |
Why?
|
| Neoplasm Metastasis | 2 | 2024 | 745 | 0.730 |
Why?
|
| Gene Regulatory Networks | 4 | 2024 | 400 | 0.730 |
Why?
|
| Neoplasms | 9 | 2024 | 3035 | 0.730 |
Why?
|
| Models, Biological | 6 | 2022 | 1538 | 0.730 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2022 | 87 | 0.730 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2022 | 134 | 0.700 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2021 | 456 | 0.700 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 91 | 0.690 |
Why?
|
| Smegmamorpha | 1 | 2020 | 2 | 0.680 |
Why?
|
| Neoplasm Proteins | 4 | 2020 | 719 | 0.680 |
Why?
|
| Stomach Neoplasms | 3 | 2024 | 565 | 0.680 |
Why?
|
| Y Chromosome | 1 | 2020 | 48 | 0.680 |
Why?
|
| Coinfection | 1 | 2022 | 183 | 0.670 |
Why?
|
| Mice | 27 | 2025 | 19044 | 0.670 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 78 | 0.660 |
Why?
|
| RNA Interference | 8 | 2017 | 548 | 0.660 |
Why?
|
| Genome-Wide Association Study | 7 | 2025 | 1880 | 0.660 |
Why?
|
| Cell Line, Tumor | 19 | 2021 | 3800 | 0.650 |
Why?
|
| Models, Statistical | 4 | 2020 | 505 | 0.650 |
Why?
|
| Appendicitis | 1 | 2021 | 130 | 0.650 |
Why?
|
| Genomics | 7 | 2020 | 1678 | 0.650 |
Why?
|
| Neutropenia | 1 | 2021 | 205 | 0.650 |
Why?
|
| Karyopherins | 2 | 2017 | 40 | 0.640 |
Why?
|
| Cell Survival | 9 | 2021 | 890 | 0.640 |
Why?
|
| Mesothelioma | 1 | 2020 | 93 | 0.620 |
Why?
|
| Repressor Proteins | 2 | 2016 | 874 | 0.620 |
Why?
|
| Genetics | 1 | 2019 | 25 | 0.620 |
Why?
|
| Psychology | 1 | 2019 | 62 | 0.610 |
Why?
|
| Trachoma | 1 | 2018 | 14 | 0.610 |
Why?
|
| Biological Evolution | 1 | 2020 | 256 | 0.610 |
Why?
|
| Chlamydia trachomatis | 1 | 2018 | 27 | 0.610 |
Why?
|
| Prognosis | 11 | 2025 | 5084 | 0.610 |
Why?
|
| Drug Discovery | 2 | 2019 | 179 | 0.590 |
Why?
|
| Middle Aged | 31 | 2025 | 29395 | 0.580 |
Why?
|
| Models, Theoretical | 7 | 2017 | 398 | 0.570 |
Why?
|
| Biguanides | 1 | 2017 | 13 | 0.570 |
Why?
|
| Lactams | 1 | 2017 | 21 | 0.560 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 168 | 0.560 |
Why?
|
| Bacteria | 2 | 2024 | 537 | 0.560 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2020 | 396 | 0.560 |
Why?
|
| MicroRNAs | 6 | 2025 | 949 | 0.560 |
Why?
|
| Female | 52 | 2025 | 72004 | 0.560 |
Why?
|
| Digoxin | 1 | 2017 | 44 | 0.560 |
Why?
|
| ras Proteins | 3 | 2016 | 146 | 0.550 |
Why?
|
| Immunoglobulin G | 12 | 2022 | 810 | 0.550 |
Why?
|
| Membrane Proteins | 6 | 2019 | 1621 | 0.540 |
Why?
|
| Aquatic Organisms | 1 | 2017 | 9 | 0.540 |
Why?
|
| Aged | 28 | 2025 | 21789 | 0.540 |
Why?
|
| Mesoderm | 1 | 2017 | 113 | 0.530 |
Why?
|
| Retrospective Studies | 19 | 2025 | 17565 | 0.530 |
Why?
|
| Health Status | 1 | 2019 | 413 | 0.520 |
Why?
|
| Autophagy | 4 | 2022 | 429 | 0.520 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 2203 | 0.520 |
Why?
|
| Caenorhabditis elegans | 2 | 2017 | 245 | 0.520 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2017 | 645 | 0.520 |
Why?
|
| Software | 2 | 2019 | 735 | 0.520 |
Why?
|
| Serologic Tests | 3 | 2022 | 130 | 0.510 |
Why?
|
| Ovarian Neoplasms | 2 | 2023 | 469 | 0.510 |
Why?
|
| Male | 44 | 2025 | 66171 | 0.510 |
Why?
|
| Culicidae | 2 | 2016 | 75 | 0.510 |
Why?
|
| Longevity | 1 | 2017 | 160 | 0.500 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 132 | 0.500 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 138 | 0.490 |
Why?
|
| Biomimetic Materials | 1 | 2015 | 14 | 0.490 |
Why?
|
| Adult | 29 | 2025 | 31944 | 0.490 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 189 | 0.490 |
Why?
|
| RNA, Small Interfering | 9 | 2020 | 720 | 0.480 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2016 | 125 | 0.470 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2015 | 10 | 0.470 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 46 | 0.470 |
Why?
|
| Depsipeptides | 1 | 2015 | 11 | 0.470 |
Why?
|
| Biomarkers | 8 | 2022 | 3431 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 4 | 2022 | 93 | 0.470 |
Why?
|
| Bupivacaine | 1 | 2015 | 29 | 0.470 |
Why?
|
| Apoptosis | 6 | 2020 | 1945 | 0.460 |
Why?
|
| Urologic Surgical Procedures | 1 | 2015 | 59 | 0.460 |
Why?
|
| Papua New Guinea | 7 | 2018 | 20 | 0.460 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2014 | 16 | 0.450 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 608 | 0.450 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2025 | 795 | 0.450 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2023 | 1357 | 0.450 |
Why?
|
| Mutation | 10 | 2025 | 6341 | 0.450 |
Why?
|
| Liposomes | 1 | 2015 | 207 | 0.440 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 90 | 0.440 |
Why?
|
| Seroepidemiologic Studies | 5 | 2022 | 146 | 0.430 |
Why?
|
| Antibody Formation | 5 | 2022 | 274 | 0.430 |
Why?
|
| Metabolic Syndrome | 1 | 2017 | 365 | 0.430 |
Why?
|
| Pharmacogenetics | 1 | 2015 | 203 | 0.430 |
Why?
|
| Protein Binding | 7 | 2021 | 1860 | 0.420 |
Why?
|
| Cell Nucleus | 1 | 2016 | 691 | 0.420 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 1416 | 0.420 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2023 | 40 | 0.420 |
Why?
|
| HeLa Cells | 5 | 2019 | 838 | 0.420 |
Why?
|
| Antimalarials | 3 | 2021 | 46 | 0.410 |
Why?
|
| Merozoites | 3 | 2019 | 5 | 0.410 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 2669 | 0.410 |
Why?
|
| Neoadjuvant Therapy | 3 | 2025 | 406 | 0.410 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2025 | 58 | 0.410 |
Why?
|
| Ribosomal Proteins | 2 | 2025 | 76 | 0.400 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2022 | 182 | 0.400 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2014 | 169 | 0.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2024 | 2137 | 0.400 |
Why?
|
| Carcinogenesis | 3 | 2022 | 363 | 0.400 |
Why?
|
| Vaccination | 3 | 2022 | 1019 | 0.390 |
Why?
|
| Longitudinal Studies | 6 | 2021 | 1510 | 0.380 |
Why?
|
| Robotic Surgical Procedures | 3 | 2025 | 232 | 0.380 |
Why?
|
| MAP Kinase Signaling System | 4 | 2017 | 324 | 0.370 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2022 | 609 | 0.360 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 7232 | 0.360 |
Why?
|
| Recurrence | 5 | 2019 | 1470 | 0.360 |
Why?
|
| Young Adult | 13 | 2022 | 9960 | 0.360 |
Why?
|
| Immunity, Innate | 5 | 2016 | 415 | 0.350 |
Why?
|
| Gene Library | 4 | 2023 | 225 | 0.350 |
Why?
|
| Infant | 15 | 2022 | 13256 | 0.340 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 1835 | 0.340 |
Why?
|
| HCT116 Cells | 5 | 2020 | 63 | 0.340 |
Why?
|
| Thailand | 6 | 2021 | 44 | 0.340 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2020 | 1013 | 0.340 |
Why?
|
| Child, Preschool | 18 | 2022 | 14895 | 0.340 |
Why?
|
| Pancreatectomy | 1 | 2011 | 152 | 0.340 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 465 | 0.330 |
Why?
|
| Base Sequence | 6 | 2025 | 3180 | 0.330 |
Why?
|
| Models, Genetic | 1 | 2013 | 790 | 0.330 |
Why?
|
| Carrier Proteins | 2 | 2006 | 1075 | 0.320 |
Why?
|
| Cohort Studies | 12 | 2024 | 5219 | 0.310 |
Why?
|
| ral GTP-Binding Proteins | 2 | 2021 | 4 | 0.310 |
Why?
|
| Child | 24 | 2024 | 25911 | 0.300 |
Why?
|
| DNA | 2 | 2021 | 1684 | 0.300 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 1108 | 0.290 |
Why?
|
| High-Throughput Screening Assays | 4 | 2017 | 110 | 0.290 |
Why?
|
| Oncogenes | 2 | 2020 | 181 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 628 | 0.280 |
Why?
|
| Adolescent | 17 | 2022 | 20643 | 0.280 |
Why?
|
| Lymph Node Excision | 2 | 2024 | 176 | 0.280 |
Why?
|
| Biological Ontologies | 2 | 2018 | 8 | 0.280 |
Why?
|
| Kenya | 5 | 2022 | 63 | 0.280 |
Why?
|
| Immunotherapy | 4 | 2022 | 750 | 0.270 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2025 | 393 | 0.270 |
Why?
|
| Lymphatic Metastasis | 3 | 2025 | 452 | 0.270 |
Why?
|
| Blood Glucose | 1 | 2011 | 1195 | 0.260 |
Why?
|
| Follow-Up Studies | 8 | 2025 | 5465 | 0.260 |
Why?
|
| Public Health | 2 | 2022 | 287 | 0.260 |
Why?
|
| Prevalence | 8 | 2022 | 2683 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 212 | 0.260 |
Why?
|
| Ubiquitin | 2 | 2004 | 151 | 0.250 |
Why?
|
| Incidence | 7 | 2024 | 3421 | 0.250 |
Why?
|
| Cell Proliferation | 4 | 2020 | 2562 | 0.250 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2024 | 106 | 0.250 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1761 | 0.250 |
Why?
|
| Microsatellite Instability | 2 | 2025 | 40 | 0.250 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 1187 | 0.250 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 845 | 0.250 |
Why?
|
| Down-Regulation | 2 | 2020 | 718 | 0.250 |
Why?
|
| Transistors, Electronic | 1 | 2025 | 2 | 0.240 |
Why?
|
| Peptide Nucleic Acids | 1 | 2025 | 2 | 0.240 |
Why?
|
| Indium | 1 | 2025 | 9 | 0.240 |
Why?
|
| Circulating MicroRNA | 1 | 2025 | 10 | 0.240 |
Why?
|
| Nanotubes, Carbon | 1 | 2025 | 20 | 0.240 |
Why?
|
| Brazil | 6 | 2024 | 138 | 0.240 |
Why?
|
| HEK293 Cells | 4 | 2023 | 824 | 0.240 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2023 | 41 | 0.240 |
Why?
|
| Liquid Biopsy | 1 | 2025 | 16 | 0.230 |
Why?
|
| Lysosomes | 2 | 2017 | 266 | 0.230 |
Why?
|
| Ghana | 2 | 2015 | 25 | 0.230 |
Why?
|
| Parrots | 1 | 2024 | 2 | 0.230 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 1205 | 0.230 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2024 | 11 | 0.230 |
Why?
|
| Seasons | 2 | 2017 | 334 | 0.230 |
Why?
|
| Pigments, Biological | 1 | 2024 | 8 | 0.230 |
Why?
|
| Feathers | 1 | 2024 | 7 | 0.230 |
Why?
|
| Exosomes | 1 | 2025 | 57 | 0.230 |
Why?
|
| Pigmentation | 1 | 2024 | 36 | 0.230 |
Why?
|
| Biosensing Techniques | 1 | 2025 | 69 | 0.230 |
Why?
|
| Bayes Theorem | 3 | 2021 | 315 | 0.230 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2024 | 45 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 3 | 2023 | 1434 | 0.220 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2025 | 1316 | 0.220 |
Why?
|
| Genes, Reporter | 2 | 2023 | 399 | 0.220 |
Why?
|
| SUMO-1 Protein | 1 | 2004 | 9 | 0.220 |
Why?
|
| Arachnoid | 1 | 2024 | 9 | 0.220 |
Why?
|
| Primaquine | 1 | 2024 | 1 | 0.220 |
Why?
|
| Nerve Growth Factor | 1 | 2004 | 24 | 0.220 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2025 | 194 | 0.220 |
Why?
|
| Dura Mater | 1 | 2024 | 26 | 0.220 |
Why?
|
| Xenopus Proteins | 1 | 2004 | 60 | 0.210 |
Why?
|
| RNA Splicing | 1 | 2025 | 252 | 0.210 |
Why?
|
| Immunoglobulin M | 2 | 2022 | 219 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 3 | 2022 | 407 | 0.210 |
Why?
|
| Cleft Lip | 1 | 2025 | 133 | 0.210 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2024 | 79 | 0.210 |
Why?
|
| Multiprotein Complexes | 3 | 2021 | 219 | 0.210 |
Why?
|
| Cleft Palate | 1 | 2025 | 153 | 0.210 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2025 | 288 | 0.200 |
Why?
|
| Nuclear Proteins | 4 | 2017 | 1351 | 0.200 |
Why?
|
| Phosphorylation | 3 | 2021 | 1713 | 0.200 |
Why?
|
| Operating Rooms | 1 | 2023 | 75 | 0.200 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 937 | 0.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 963 | 0.200 |
Why?
|
| Dysbiosis | 1 | 2024 | 145 | 0.200 |
Why?
|
| Cell Differentiation | 2 | 2015 | 2043 | 0.200 |
Why?
|
| Snail Family Transcription Factors | 1 | 2022 | 26 | 0.200 |
Why?
|
| Plasmodium knowlesi | 1 | 2022 | 3 | 0.200 |
Why?
|
| Antibody Affinity | 1 | 2022 | 41 | 0.200 |
Why?
|
| Recombinant Proteins | 4 | 2017 | 1436 | 0.200 |
Why?
|
| Surgical Stapling | 1 | 2022 | 18 | 0.190 |
Why?
|
| Receptors, Androgen | 2 | 2023 | 434 | 0.190 |
Why?
|
| Genotype | 2 | 2019 | 2822 | 0.190 |
Why?
|
| Lymph Nodes | 1 | 2024 | 397 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 1 | 2024 | 166 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2025 | 2949 | 0.190 |
Why?
|
| Erythrocytes | 3 | 2020 | 234 | 0.190 |
Why?
|
| Peritoneum | 1 | 2022 | 40 | 0.190 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2023 | 99 | 0.190 |
Why?
|
| Immune System | 1 | 2022 | 98 | 0.180 |
Why?
|
| Spermatids | 1 | 2021 | 27 | 0.180 |
Why?
|
| Cell Line | 7 | 2025 | 2863 | 0.180 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 165 | 0.180 |
Why?
|
| Treatment Outcome | 8 | 2025 | 13098 | 0.180 |
Why?
|
| Dietary Fiber | 1 | 2021 | 83 | 0.180 |
Why?
|
| Disease Transmission, Infectious | 2 | 2019 | 87 | 0.180 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 1922 | 0.180 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2021 | 46 | 0.180 |
Why?
|
| CTLA-4 Antigen | 1 | 2021 | 68 | 0.180 |
Why?
|
| Platinum Compounds | 1 | 2020 | 6 | 0.170 |
Why?
|
| Pemetrexed | 1 | 2020 | 9 | 0.170 |
Why?
|
| Transfection | 3 | 2011 | 1098 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2022 | 188 | 0.170 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2021 | 44 | 0.170 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3978 | 0.170 |
Why?
|
| Perfusion | 1 | 2022 | 214 | 0.170 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 72 | 0.170 |
Why?
|
| Vesicular Transport Proteins | 2 | 2015 | 123 | 0.170 |
Why?
|
| Sex Determination Processes | 1 | 2020 | 13 | 0.170 |
Why?
|
| Portal Vein | 1 | 2021 | 95 | 0.170 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2020 | 94 | 0.170 |
Why?
|
| Enzyme Activation | 4 | 2006 | 651 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 137 | 0.170 |
Why?
|
| Thrombospondin 1 | 1 | 2020 | 25 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 50 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 56 | 0.170 |
Why?
|
| Viruses | 1 | 2021 | 128 | 0.160 |
Why?
|
| Emergencies | 1 | 2021 | 187 | 0.160 |
Why?
|
| Fungal Proteins | 1 | 2020 | 143 | 0.160 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 3758 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2023 | 6610 | 0.160 |
Why?
|
| Biopsy | 1 | 2023 | 1301 | 0.160 |
Why?
|
| DNA Transposable Elements | 1 | 2020 | 189 | 0.160 |
Why?
|
| Genes, Neoplasm | 1 | 2020 | 91 | 0.160 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 306 | 0.160 |
Why?
|
| Age Factors | 4 | 2019 | 2997 | 0.150 |
Why?
|
| Gene Expression | 1 | 2004 | 1622 | 0.150 |
Why?
|
| Pacific Islands | 1 | 2018 | 5 | 0.150 |
Why?
|
| Phenotype | 2 | 2019 | 4605 | 0.150 |
Why?
|
| Nepal | 1 | 2018 | 14 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2021 | 709 | 0.150 |
Why?
|
| Probiotics | 1 | 2021 | 229 | 0.150 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 45 | 0.150 |
Why?
|
| Tanzania | 2 | 2016 | 73 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 2170 | 0.150 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 129 | 0.150 |
Why?
|
| Acrylamides | 1 | 2018 | 25 | 0.150 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2018 | 21 | 0.150 |
Why?
|
| Calibration | 1 | 2018 | 100 | 0.150 |
Why?
|
| DNA Primers | 2 | 2013 | 672 | 0.150 |
Why?
|
| Surgeons | 1 | 2023 | 285 | 0.150 |
Why?
|
| Geography | 1 | 2018 | 126 | 0.150 |
Why?
|
| Interferon Regulatory Factor-3 | 2 | 2015 | 19 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 4882 | 0.140 |
Why?
|
| Starvation | 1 | 2017 | 18 | 0.140 |
Why?
|
| Autophagosomes | 1 | 2017 | 30 | 0.140 |
Why?
|
| Insect Vectors | 2 | 2016 | 114 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1167 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2020 | 914 | 0.140 |
Why?
|
| Influenza in Birds | 1 | 2017 | 30 | 0.140 |
Why?
|
| Ethiopia | 1 | 2017 | 23 | 0.140 |
Why?
|
| Vesiculovirus | 2 | 2014 | 16 | 0.140 |
Why?
|
| Abdominal Injuries | 2 | 2010 | 117 | 0.140 |
Why?
|
| Interferons | 2 | 2015 | 144 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2017 | 827 | 0.140 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 33 | 0.140 |
Why?
|
| Birds | 1 | 2017 | 87 | 0.140 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 62 | 0.130 |
Why?
|
| Phosphoproteins | 2 | 2016 | 458 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 96 | 0.130 |
Why?
|
| Genome, Protozoan | 1 | 2017 | 26 | 0.130 |
Why?
|
| Machine Learning | 1 | 2020 | 339 | 0.130 |
Why?
|
| Follistatin-Related Proteins | 1 | 2016 | 2 | 0.130 |
Why?
|
| Disease Resistance | 1 | 2017 | 28 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 249 | 0.130 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2016 | 35 | 0.130 |
Why?
|
| Metabolome | 1 | 2019 | 322 | 0.130 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2016 | 31 | 0.130 |
Why?
|
| Porphyrins | 1 | 2016 | 18 | 0.130 |
Why?
|
| Aurora Kinase A | 1 | 2017 | 38 | 0.130 |
Why?
|
| Spatial Analysis | 1 | 2016 | 25 | 0.130 |
Why?
|
| Influenza A virus | 1 | 2017 | 152 | 0.130 |
Why?
|
| Genes, Lethal | 1 | 2016 | 77 | 0.130 |
Why?
|
| Basic Reproduction Number | 1 | 2016 | 2 | 0.130 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2015 | 22 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 149 | 0.130 |
Why?
|
| Piperidines | 1 | 2018 | 240 | 0.130 |
Why?
|
| Endosomes | 1 | 2016 | 68 | 0.130 |
Why?
|
| Infant, Newborn | 4 | 2019 | 8636 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2021 | 1493 | 0.130 |
Why?
|
| Peptide Library | 1 | 2016 | 61 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 241 | 0.120 |
Why?
|
| Sporozoites | 1 | 2015 | 4 | 0.120 |
Why?
|
| Plasmodium ovale | 1 | 2015 | 2 | 0.120 |
Why?
|
| Tropical Climate | 1 | 2016 | 51 | 0.120 |
Why?
|
| Mental Health | 1 | 2019 | 374 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2017 | 215 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 39 | 0.120 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 116 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 470 | 0.120 |
Why?
|
| Asymptomatic Infections | 3 | 2022 | 38 | 0.120 |
Why?
|
| Acetyltransferases | 1 | 2015 | 92 | 0.120 |
Why?
|
| Simuliidae | 1 | 2015 | 4 | 0.120 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2015 | 5 | 0.120 |
Why?
|
| Aspartic Acid | 1 | 2015 | 86 | 0.120 |
Why?
|
| Thiolester Hydrolases | 1 | 2015 | 10 | 0.120 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 102 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2017 | 253 | 0.120 |
Why?
|
| Onchocerca volvulus | 1 | 2015 | 16 | 0.120 |
Why?
|
| Onchocerciasis | 1 | 2015 | 22 | 0.120 |
Why?
|
| Vaccines, Subunit | 1 | 2015 | 70 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2016 | 234 | 0.120 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 1626 | 0.120 |
Why?
|
| Piperazines | 1 | 2017 | 256 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 271 | 0.120 |
Why?
|
| DNA Repair | 2 | 2015 | 638 | 0.110 |
Why?
|
| Immunization, Secondary | 1 | 2015 | 113 | 0.110 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 320 | 0.110 |
Why?
|
| Melanesia | 3 | 2020 | 9 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 64 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 389 | 0.110 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2014 | 40 | 0.110 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 74 | 0.110 |
Why?
|
| Gambia | 1 | 2014 | 29 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2015 | 173 | 0.110 |
Why?
|
| Glycolysis | 1 | 2014 | 173 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2016 | 483 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2015 | 249 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 378 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2024 | 1630 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2015 | 370 | 0.100 |
Why?
|
| Base Composition | 1 | 2013 | 75 | 0.100 |
Why?
|
| Genome | 1 | 2016 | 529 | 0.100 |
Why?
|
| Pain Management | 1 | 2015 | 200 | 0.100 |
Why?
|
| Vitamin D | 1 | 2014 | 180 | 0.100 |
Why?
|
| Length of Stay | 3 | 2015 | 1390 | 0.100 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 296 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 278 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 249 | 0.100 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 653 | 0.100 |
Why?
|
| Calcium | 1 | 2017 | 1148 | 0.100 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2012 | 14 | 0.100 |
Why?
|
| Transcriptome | 1 | 2019 | 1135 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 454 | 0.100 |
Why?
|
| Mitochondria | 1 | 2017 | 759 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2015 | 406 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 265 | 0.100 |
Why?
|
| Cytokines | 1 | 2018 | 1397 | 0.090 |
Why?
|
| RNA | 1 | 2016 | 607 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 278 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 678 | 0.090 |
Why?
|
| Peru | 2 | 2022 | 56 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2014 | 427 | 0.090 |
Why?
|
| Laparotomy | 2 | 2010 | 143 | 0.090 |
Why?
|
| Brain | 1 | 2024 | 3225 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2012 | 89 | 0.090 |
Why?
|
| Fluorescence | 2 | 2022 | 103 | 0.090 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2011 | 20 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 3056 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 151 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2011 | 105 | 0.090 |
Why?
|
| Plasmids | 2 | 2020 | 531 | 0.090 |
Why?
|
| Cryosurgery | 1 | 2011 | 49 | 0.090 |
Why?
|
| Intestinal Obstruction | 1 | 2012 | 97 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2011 | 300 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 2177 | 0.090 |
Why?
|
| Medical Futility | 1 | 2010 | 39 | 0.080 |
Why?
|
| Postoperative Period | 1 | 2011 | 339 | 0.080 |
Why?
|
| Liver | 1 | 2017 | 1876 | 0.080 |
Why?
|
| Exome | 1 | 2015 | 1087 | 0.080 |
Why?
|
| Kinetics | 2 | 2022 | 1353 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 2011 | 202 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 619 | 0.080 |
Why?
|
| Cystectomy | 1 | 2010 | 165 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1044 | 0.080 |
Why?
|
| Trauma Centers | 1 | 2010 | 198 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1982 | 0.080 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2010 | 187 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2011 | 248 | 0.070 |
Why?
|
| Africa | 2 | 2021 | 142 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 3180 | 0.070 |
Why?
|
| Endoscopy | 1 | 2010 | 287 | 0.070 |
Why?
|
| Disease Eradication | 2 | 2020 | 39 | 0.070 |
Why?
|
| Palliative Care | 1 | 2012 | 464 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2011 | 1338 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2017 | 510 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2025 | 676 | 0.070 |
Why?
|
| Metabolomics | 2 | 2022 | 470 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 491 | 0.070 |
Why?
|
| Algorithms | 4 | 2017 | 1738 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2020 | 615 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 158 | 0.070 |
Why?
|
| Rats | 2 | 2004 | 3876 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 1051 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2011 | 462 | 0.070 |
Why?
|
| Alleles | 2 | 2025 | 1724 | 0.060 |
Why?
|
| Glutamine | 2 | 2019 | 222 | 0.060 |
Why?
|
| Logistic Models | 1 | 2011 | 1908 | 0.060 |
Why?
|
| Trypsin | 1 | 2006 | 94 | 0.060 |
Why?
|
| Genes, myc | 2 | 2017 | 107 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2012 | 773 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2018 | 780 | 0.060 |
Why?
|
| Transcription Factor AP-2 | 1 | 2025 | 23 | 0.060 |
Why?
|
| Limit of Detection | 1 | 2025 | 77 | 0.060 |
Why?
|
| Interferon Regulatory Factors | 1 | 2025 | 43 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2010 | 561 | 0.060 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2025 | 24 | 0.060 |
Why?
|
| RNA Splice Sites | 1 | 2025 | 99 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 546 | 0.060 |
Why?
|
| Protein Kinases | 2 | 2004 | 345 | 0.060 |
Why?
|
| Nucleic Acid Conformation | 1 | 2025 | 200 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 2265 | 0.060 |
Why?
|
| Color | 1 | 2024 | 35 | 0.060 |
Why?
|
| Smad4 Protein | 1 | 2025 | 58 | 0.060 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 225 | 0.060 |
Why?
|
| Stomach | 1 | 2007 | 272 | 0.060 |
Why?
|
| Receptor, Notch1 | 1 | 2025 | 80 | 0.060 |
Why?
|
| Keratinocytes | 1 | 2024 | 66 | 0.060 |
Why?
|
| Poly I-C | 2 | 2015 | 25 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2004 | 28 | 0.060 |
Why?
|
| Cambodia | 1 | 2024 | 12 | 0.050 |
Why?
|
| Introns | 1 | 2025 | 319 | 0.050 |
Why?
|
| Colectomy | 1 | 2025 | 84 | 0.050 |
Why?
|
| CA-19-9 Antigen | 1 | 2024 | 10 | 0.050 |
Why?
|
| Forests | 1 | 2024 | 15 | 0.050 |
Why?
|
| Colorectal Surgery | 1 | 2004 | 10 | 0.050 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2024 | 17 | 0.050 |
Why?
|
| Subarachnoid Space | 1 | 2024 | 25 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2024 | 15 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 1087 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 19 | 0.050 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2024 | 22 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 1332 | 0.050 |
Why?
|
| Neurites | 1 | 2004 | 46 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2022 | 1595 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2024 | 47 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2015 | 4012 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2004 | 129 | 0.050 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 71 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2024 | 99 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2011 | 3752 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 468 | 0.050 |
Why?
|
| Registries | 1 | 2010 | 1586 | 0.050 |
Why?
|
| Veins | 1 | 2024 | 108 | 0.050 |
Why?
|
| Protein Domains | 1 | 2024 | 260 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 174 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 315 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 805 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2017 | 225 | 0.050 |
Why?
|
| beta Catenin | 1 | 2025 | 232 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2024 | 416 | 0.050 |
Why?
|
| Biological Transport | 1 | 2024 | 371 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 638 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 361 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 232 | 0.050 |
Why?
|
| Cell Death | 2 | 2014 | 251 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 143 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2025 | 390 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 7 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2004 | 182 | 0.050 |
Why?
|
| Acetyl Coenzyme A | 1 | 2022 | 15 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 367 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2022 | 61 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2025 | 440 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2024 | 843 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 93 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2022 | 54 | 0.050 |
Why?
|
| Telomerase | 2 | 2014 | 179 | 0.050 |
Why?
|
| Plant Proteins | 1 | 2002 | 91 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 289 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 127 | 0.050 |
Why?
|
| Acetylation | 1 | 2022 | 195 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 38 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 47 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 1138 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2024 | 251 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 217 | 0.050 |
Why?
|
| Fertilization | 1 | 2021 | 45 | 0.050 |
Why?
|
| Asia, Southeastern | 1 | 2021 | 22 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 38 | 0.050 |
Why?
|
| Blastocyst | 1 | 2021 | 79 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2021 | 36 | 0.040 |
Why?
|
| Cholangiography | 1 | 2021 | 15 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 487 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 920 | 0.040 |
Why?
|
| Cytosol | 1 | 2021 | 168 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2021 | 78 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 283 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 1144 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 1391 | 0.040 |
Why?
|
| Gene Order | 1 | 2020 | 82 | 0.040 |
Why?
|
| Cholecystectomy | 1 | 2021 | 64 | 0.040 |
Why?
|
| Indocyanine Green | 1 | 2021 | 62 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 167 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2015 | 624 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 204 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2021 | 178 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1764 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 444 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 513 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 322 | 0.040 |
Why?
|
| ROC Curve | 1 | 2022 | 611 | 0.040 |
Why?
|
| Risk Factors | 3 | 2025 | 11184 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 85 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2021 | 224 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 482 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 318 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2020 | 201 | 0.040 |
Why?
|
| Complement Fixation Tests | 1 | 2019 | 34 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 1070 | 0.040 |
Why?
|
| Proteomics | 1 | 2003 | 603 | 0.040 |
Why?
|
| Complement C1q | 1 | 2019 | 20 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 448 | 0.040 |
Why?
|
| Morbidity | 2 | 2012 | 256 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2019 | 113 | 0.040 |
Why?
|
| Trauma Severity Indices | 2 | 2010 | 86 | 0.040 |
Why?
|
| Computational Biology | 2 | 2017 | 890 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 161 | 0.040 |
Why?
|
| Time Factors | 3 | 2020 | 6592 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2019 | 162 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 855 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2021 | 291 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 196 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 542 | 0.040 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2017 | 11 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2538 | 0.040 |
Why?
|
| Parasitemia | 1 | 2017 | 26 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 789 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 111 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2011 | 38 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 625 | 0.030 |
Why?
|
| Half-Life | 1 | 2017 | 162 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 2771 | 0.030 |
Why?
|
| Commerce | 1 | 2017 | 57 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2017 | 101 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3867 | 0.030 |
Why?
|
| Immune Sera | 1 | 2017 | 94 | 0.030 |
Why?
|
| China | 1 | 2017 | 296 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2017 | 63 | 0.030 |
Why?
|
| Triticum | 1 | 2017 | 39 | 0.030 |
Why?
|
| Buffers | 1 | 2016 | 32 | 0.030 |
Why?
|
| Uganda | 1 | 2017 | 89 | 0.030 |
Why?
|
| Kidney | 1 | 2004 | 1404 | 0.030 |
Why?
|
| Anoikis | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 67 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 94 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 174 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 751 | 0.030 |
Why?
|
| Equatorial Guinea | 1 | 2015 | 1 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 223 | 0.030 |
Why?
|
| RNA Editing | 1 | 2016 | 36 | 0.030 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2015 | 15 | 0.030 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 276 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2015 | 29 | 0.030 |
Why?
|
| K562 Cells | 1 | 2015 | 100 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2015 | 78 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 176 | 0.030 |
Why?
|
| Exodeoxyribonucleases | 1 | 2015 | 52 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 98 | 0.030 |
Why?
|
| Germ Cells | 1 | 2017 | 204 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2015 | 105 | 0.030 |
Why?
|
| Response Elements | 1 | 2015 | 108 | 0.030 |
Why?
|
| Immunization Schedule | 1 | 2015 | 107 | 0.030 |
Why?
|
| Africa, Western | 1 | 2015 | 15 | 0.030 |
Why?
|
| Ovum | 1 | 2015 | 17 | 0.030 |
Why?
|
| Pupa | 1 | 2015 | 23 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 96 | 0.030 |
Why?
|
| Exocytosis | 1 | 2015 | 66 | 0.030 |
Why?
|
| Placebos | 1 | 2015 | 239 | 0.030 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2014 | 12 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2015 | 52 | 0.030 |
Why?
|
| Genome, Human | 2 | 2013 | 1350 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2016 | 136 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 86 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2014 | 11 | 0.030 |
Why?
|
| Glucose | 1 | 2019 | 926 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 295 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 157 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 442 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 907 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 440 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 169 | 0.030 |
Why?
|
| Vero Cells | 1 | 2014 | 113 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1193 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 262 | 0.030 |
Why?
|
| Climate Change | 1 | 2015 | 62 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2015 | 247 | 0.030 |
Why?
|
| Temperature | 1 | 2015 | 327 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3508 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 131 | 0.030 |
Why?
|
| Bronchi | 1 | 2014 | 108 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 183 | 0.030 |
Why?
|
| Indoles | 1 | 2015 | 204 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 207 | 0.030 |
Why?
|
| United States | 2 | 2025 | 11777 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 633 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 798 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 419 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2015 | 289 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1771 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 563 | 0.020 |
Why?
|
| Systems Biology | 1 | 2013 | 63 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 424 | 0.020 |
Why?
|
| Testis | 1 | 2015 | 433 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 214 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 709 | 0.020 |
Why?
|
| North Carolina | 1 | 2012 | 66 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 596 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2012 | 54 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2012 | 34 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 811 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2012 | 253 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 572 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2004 | 3170 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 401 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1664 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 532 | 0.020 |
Why?
|
| Ohio | 1 | 2011 | 87 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 69 | 0.020 |
Why?
|
| Genes, ras | 1 | 2011 | 102 | 0.020 |
Why?
|
| Laparoscopes | 1 | 2010 | 5 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2010 | 38 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 623 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2793 | 0.020 |
Why?
|
| Urinary Diversion | 1 | 2010 | 44 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 360 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2010 | 72 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 399 | 0.020 |
Why?
|
| Pelvis | 1 | 2010 | 74 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 937 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2010 | 234 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2015 | 814 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1036 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2010 | 303 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7600 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 609 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3677 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1161 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 918 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 827 | 0.020 |
Why?
|
| Shock, Traumatic | 1 | 2007 | 7 | 0.020 |
Why?
|
| Michigan | 1 | 2007 | 52 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1595 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2010 | 1097 | 0.010 |
Why?
|
| Urban Population | 1 | 2007 | 244 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 79 | 0.010 |
Why?
|
| Streptavidin | 1 | 2003 | 4 | 0.010 |
Why?
|
| Biotinylation | 1 | 2003 | 23 | 0.010 |
Why?
|
| Microspheres | 1 | 2003 | 75 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 334 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2002 | 12 | 0.010 |
Why?
|
| Sorbitol | 1 | 2002 | 9 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2002 | 52 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 97 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2002 | 67 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 115 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 319 | 0.010 |
Why?
|
| Proteome | 1 | 2003 | 282 | 0.010 |
Why?
|
| Ligands | 1 | 2002 | 571 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 319 | 0.010 |
Why?
|
| Drosophila | 1 | 2002 | 829 | 0.010 |
Why?
|